tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adam Maeder, 190 are a BUY (72.8%), 64 are a HOLD (24.52%), 7 are a SELL (2.68%).
Analyst Adam Maeder, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 63.03% that have a potential upside of 30.98% achieved within 94 days.
Adam Maeder’s has documented 523 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on EW, Edwards Lifesciences Corp at 12-Feb-2025.
Analyst best performing recommendations are on RBOT (VICARIOUS SURGICAL).
The best stock recommendation documented was for RBOT (VICARIOUS SURGICAL) at 11/13/2024. The price target of $10.5 was fulfilled within 1 day with a profit of $1.35 (14.75%) receiving and performance score of 147.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
$13
2 years 1 months 16 days ago
(23-Jan-2023)
1/2 (50%)
$0.16 (1.63%)
70
Hold
$10
$10
2 years 2 months 7 days ago
(04-Jan-2023)
3/4 (75%)
$0.12 (1.21%)
193
Hold
$10
$14
2 years 3 months 9 days ago
(30-Nov-2022)
1/5 (20%)
$-0.13 (-1.28%)
13
Buy
$9
$-1 (-10.00%)
$13
2 years 10 months 7 days ago
(04-May-2022)
1/3 (33.33%)
$3.44 (61.87%)
209
Buy
$12
$2 (20.00%)
$14
3 years 16 days ago
(23-Feb-2022)
9/13 (69.23%)
$6.64 (123.88%)
124
Which stock is Adam Maeder is most bullish on?
Which stock is Adam Maeder is most reserved on?
What Year was the first public recommendation made by Adam Maeder?
